ADAMTS-13 antigen and activity levels in thrombocytopenic disorders including thrombotic thrombocytopenic purpura in Kuwait

Acta Haematologica

Volumn 125, Issue 3, 2011, Pages 160-166

  Al Awadhi, A M ^a   Jadaon, M M ^a   Al Jafar, H A ^b   Al Wazzan, H J ^c  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL AMIRI HOSPITAL   (Kuwait)

^c Department of Hematology   (Kuwait)

Author keywords

ADAMTS 13 protease; Thrombotic thrombocytopenic purpura; von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HEPATITIS; HUMAN; KUWAIT; LYMPHATIC LEUKEMIA; MALE; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PANCYTOPENIA; PRIORITY JOURNAL; SEPSIS; SEPTICEMIA; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADULT; AGED; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KUWAIT; MALE; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC; THROMBOCYTOPENIA; VON WILLEBRAND FACTOR;

EID: 78650645207     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322391     Document Type: Article

References (28)

1. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD: Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 78: 1456-1461. (Pubitemid 17219507)
2. Sporn LA, Marder VJ, Wagner DD: von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood 1987; 69: 1531-1534. (Pubitemid 17085319)
3. Furlan M, Robles R, Lamie B: Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996; 87: 4223-4234. (Pubitemid 26152266)
4. Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K: Structure of von Willebrand factor-cleaving protease (ADAMTS-13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001; 276: 41059-41063.
5. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D: Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432-1435. (Pubitemid 13234018)
6. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lömmle B: Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenicpurpura. Blood 1997; 89: 3097-3103. (Pubitemid 27229791)
7. Tsai H-M, Lian EC: Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-1594. (Pubitemid 28536133)
8. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lömmle B: von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic- uremic syndrome. N Engl J Med 1998; 339: 1578-1584. (Pubitemid 28536132)
9. Furlan M, Lammle B: Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura. Baillieres Clin Haematol 1998; 11: 509-514. (Pubitemid 29103560)
10. Bianchi V, Robles R, Alberio L, Furlan M, Lammle B: von Willebrand factor cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood 2002; 100: 710-713. (Pubitemid 34761143)
11. Tsai HM: Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes. J Thromb Haemost 2003; 1: 625-631.
12. George JN: The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.Clin Adv Hematol Oncol 2005; 3: 627-632. (Pubitemid 41403804)
13. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E: Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001; 98: 2730-2735.
14. Moore JC, Hayward CP, Warkentin TE, Kelton JG: Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood 2001; 98: 1842-1846.
15. Levi M, Toc CH, Thachil J, Watson HG: Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009; 145: 24-33.
16. Mannucci PM, Peyvandi F: TTP and ADAMTS13: when is testing appropriate? Hematology 2007: 121-126.
17. Peyvandi F, Ferrari S, Lavoretano S, Canciani MT, Mannucci PM: von Willebrand factor-cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura. Br J Haematol 2004; 127: 433- 439. (Pubitemid 39536596)
18. Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J: Elevated circulating E-selectin, intracellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998; 157: 776-784.
19. Kremer Hovinga JA, Zeerleder S, Kessler P, Romani de Wit T, van Mourik JA, Hack CE, ten Cate H, Reitsma PH, Wuillemin WA, Lömmle B: ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J Thromb Haemost 2007; 5: 2284-2290. (Pubitemid 47617882)
20. Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF: Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 2004; 104: 100-106. (Pubitemid 38879844)
21. Zhou W, Inada M, Lee TP, Benten D, Lyubsky S, Bouhassira EE, Gupta S, Tsai HM: ADAMTS-13 is expressed in hepatic stellate cells. Lab Invest 2005; 85: 780-788. (Pubitemid 40799707)
22. Uemura M, Fujimura Y, Matsumoto M, Ishizashi H, Kato S, Matsuyama T, Isonishi A, Ishikawa M, Yagita M, Morioka C, Yoshiji H, Tsujimoto T, Kurumatani N, Fukui H: Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis. Thromb Haemost 2008; 99: 1019-1029. (Pubitemid 351810483)
23. Feys H, Canciani M, Peyvandi F, Deckmyn H, Vanhoorelbeke K, Mannucci PM: ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis. Br J Haematol 2007; 138: 534-540. (Pubitemid 47063038)
24. Ferro D, Quintarelli C, Lattuada A, Leo R, Alessandroni M, Mannucci PM, Violi F: High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxins. Hepatology 1996; 23: 1377-1383. (Pubitemid 26181219)
25. Motto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, Desch KC, Zhang W, Tsai HM, Wagner DD, Ginsburg D: Additional environmental and/or genetic factors are required to trigger TTP in ADAMTS13-deficient mice. Blood 2004; 104: 77a.
26. Chang JC, El-Tarabily M, Gupta S: Acute thrombotic thrombocytopenic purpura following abdominal surgeries: a report of three cases. J Clin Apher 2000; 15: 176-179.
27. McDonald V, Laffan M, Benjamin S, Bevan D, Machin S, Scully MA: Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry. Br J Haematol 2009; 144: 430-433.
28. Douglas KW, Pollock KG, Young D, Catlow J, Green R: Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: A single-institution experience. J Clin Apher 2010; 25: 47-53.